Crossmark

IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy

Crossref DOI link: https://doi.org/10.1007/s11060-014-1443-0

Published Online: 2014-04-20

Published Print: 2014-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Minniti, Giuseppe

Scaringi, Claudia

Arcella, Antonella

Lanzetta, Gaetano

Di Stefano, Domenica

Scarpino, Stefania

Bozzao, Alessandro

Pace, Andrea

Villani, Veronica

Salvati, Maurizio

Esposito, Vincenzo

Giangaspero, Felice

Enrici, Riccardo Maurizi
License Information

Text and Data Mining valid from 2014-04-20